Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNP318 in Diabetic Macular Edema
NCT07199777Phase 2Not yet recruiting
- Sponsor
- SciNeuro Pharmaceuticals
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of snp318 in diabetic macular edema (DME), sponsored by SciNeuro Pharmaceuticals. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
snp318
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07199777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07199777.